70 related articles for article (PubMed ID: 21895959)
1. What women want. Women's preferences for the management of low-grade abnormal cervical screening tests: a systematic review.
Frederiksen ME; Lynge E; Rebolj M
BJOG; 2012 Jan; 119(1):7-19. PubMed ID: 21895959
[TBL] [Abstract][Full Text] [Related]
2. Women's preferences regarding options for management of atypical, borderline or low-grade cervical cytological abnormalities: a review of the evidence.
Sadique MZ; Legood R
Cytopathology; 2012 Jun; 23(3):161-6. PubMed ID: 21658136
[TBL] [Abstract][Full Text] [Related]
3. Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology.
O'Connor M; Costello L; Murphy J; Prendiville W; Martin CM; O'Leary JJ; Sharp L;
J Fam Plann Reprod Health Care; 2015 Apr; 41(2):134-41. PubMed ID: 25248873
[TBL] [Abstract][Full Text] [Related]
4. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
6. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
[TBL] [Abstract][Full Text] [Related]
7. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
McCaffery K; Irwig L
J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
[TBL] [Abstract][Full Text] [Related]
8. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
9. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
[TBL] [Abstract][Full Text] [Related]
10. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
11. What Australian women want and when they want it: cervical screening testing preferences, decision-making styles and information needs.
Dieng M; Trevena L; Turner RM; Wadolowski M; McCaffery K
Health Expect; 2013 Jun; 16(2):177-88. PubMed ID: 21726363
[TBL] [Abstract][Full Text] [Related]
12. Psychological effects of diagnosis and treatment of cervical intraepithelial neoplasia: a systematic review.
Frederiksen ME; Njor S; Lynge E; Rebolj M
Sex Transm Infect; 2015 Jun; 91(4):248-56. PubMed ID: 25512668
[TBL] [Abstract][Full Text] [Related]
13. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.
McCaffery K; Waller J; Forrest S; Cadman L; Szarewski A; Wardle J
BJOG; 2004 Dec; 111(12):1437-43. PubMed ID: 15663132
[TBL] [Abstract][Full Text] [Related]
14. HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice.
McCaffery KJ; Irwig L; Chan SF; Macaskill P; Barratt A; Lewicka M; Clarke J; Weisberg E
Patient Educ Couns; 2008 Dec; 73(3):473-9, 481. PubMed ID: 18757164
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
16. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
17. Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval.
Ogilvie GS; Smith LW; van Niekerk D; Khurshed F; Pedersen HN; Taylor D; Thomson K; Greene SB; Babich SM; Franco EL; Coldman AJ
BMC Public Health; 2016 Mar; 16():213. PubMed ID: 26935960
[TBL] [Abstract][Full Text] [Related]
18. Development and field testing of a tool to elicit women's preferences among cervical cancer screening modalities.
Wood B; Taljaard M; El-Khatib Z; McFaul S; Graham ID; Little J
J Eval Clin Pract; 2019 Dec; 25(6):1169-1181. PubMed ID: 31423705
[TBL] [Abstract][Full Text] [Related]
19. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
Tota J; Mahmud SM; Ferenczy A; Coutlée F; Franco EL
Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
[TBL] [Abstract][Full Text] [Related]
20. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]